{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T05:21:25Z","timestamp":1787721685572,"version":"build-2784847793"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Urol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Penile cancer (PeCA) presents high morbidity and mortality and is more prevalent in underdeveloped countries. The presence of nodal metastasis at diagnosis or as early recurrence carries a worse prognosis, making it important to determine whether clinically relevant biomarkers are maintained between primary tumors and corresponding lymph node metastases. We aim to describe the presence of DNA microsatellite instability (MSI) in primary PeCA tumors and locoregional lymph nodes affected by metastatic cells, as well as to assess HPV status through p16 expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 116 patients were comparatively evaluated between the primary tumor and lymph node metastases. The evaluation of p16 and mismatch repair proteins was done by immunohistochemistry, and MSI status was assessed using a hexa-plex marker by polymerase chain reaction, followed by fragment analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All patients underwent a standard lymphadenectomy (inguinal or pelvic), with a pN0 frequency of 33.6%. MSI-H was found in three patients (2.6%), with correspondence between the presence of the biomarker in the primary tumors and the lymph node metastases. A second validation was performed using IHC for MMR, with MLH1\/PMS2 loss in MSI-H cases. 22.8% of patients expressed p16 by immunohistochemistry. p16 positivity was associated with a 55% reduction in the risk of death. All MSI-H patients were p16 positive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MSI-H occurs in 2,6% of the sample and is associated predominantly with MLH1\/PMS2 loss and p16 positivity. Together, these findings suggest potential interactions between HPV- associated carcinogenesis and genomic instability. Further prospective, biomarker-driven trials are warranted to define their prognostic and therapeutic relevance in PeCA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fruro.2026.1908537","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T04:44:03Z","timestamp":1787719443000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Microsatellite instability in penile cancer: comparative analysis of primary tumors and metastases"],"prefix":"10.3389","volume":"6","author":[{"given":"Hadson Silva","family":"Araujo","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Barretos Cancer Hospital","place":["Barretos, Brazil"]},{"name":"Molecular Oncology Research Center, Barretos Cancer Hospital","place":["Barretos, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Ramos","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Barretos School of Health Sciences Dr. Paulo Prata \u2013 FACISB","place":["Barretos, Brazil"]},{"name":"Pathology Department, Barretos Cancer Hospital","place":["Barretos, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"Laus","sequence":"additional","affiliation":[{"name":"Molecular Oncology Research Center, Barretos Cancer Hospital","place":["Barretos, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Noriz","family":"Berardinelli","sequence":"additional","affiliation":[{"name":"Molecular Oncology Research Center, Barretos Cancer Hospital","place":["Barretos, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel D Almeida","family":"Preto","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Barretos Cancer Hospital","place":["Barretos, Brazil"]},{"name":"Molecular Oncology Research Center, Barretos Cancer Hospital","place":["Barretos, Brazil"]},{"name":"Barretos School of Health Sciences Dr. Paulo Prata \u2013 FACISB","place":["Barretos, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui Manuel","family":"Reis","sequence":"additional","affiliation":[{"name":"Molecular Oncology Research Center, Barretos Cancer Hospital","place":["Barretos, Brazil"]},{"name":"Life and Health Sciences Research Institute (ICVS), Medical School, University of Minho","place":["Braga, Portugal"]},{"name":"3ICVS\/3B\u2019s-PT Government Associate Laboratory","place":["Braga, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio Mavignier","family":"C\u00e1rcano","sequence":"additional","affiliation":[{"name":"Molecular Oncology Research Center, Barretos Cancer Hospital","place":["Barretos, Brazil"]},{"name":"Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR)","place":["S\u00e3o Paulo, Brazil"]},{"name":"Faculdade de Ci\u00eancias M\u00e9dicas de Minas Gerais","place":["Belo Horizonte, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1590\/s1677-55382008000500007","article-title":"Epidemiologic study on penile cancer in Brazil","volume":"34","author":"Favorito","year":"2008","journal-title":"Int Braz J Urol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.1999.1071","article-title":"Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997","volume":"82","author":"Wabinga","year":"2000","journal-title":"Br J Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2010.03.003","article-title":"Epidemiology and natural history of penile cancer","volume":"76","author":"Pow-Sang","year":"2010","journal-title":"Urology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/jnci\/85.1.19","article-title":"History of circumcision, medical conditions, and sexual activity and risk of penile cancer","volume":"85","author":"Maden","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000238411.75324.59","article-title":"Trends in cancer risk among people with AIDS in the United States 1980-2002","volume":"20","author":"Engels","year":"2006","journal-title":"AIDS"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)00735-4","article-title":"Penile carcinoma in patients with genital lichen sclerosus: a multicenter survey","volume":"175","author":"Barbagli","year":"2006","journal-title":"J Urol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199004193221601","article-title":"Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study","volume":"322","author":"Stern","year":"1990","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 world health organization classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours","volume":"82","author":"Moch","year":"2022","journal-title":"Eur Urol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.02.025","article-title":"Long-term followup of penile carcinoma with high risk for lymph node invasion treated with inguinal lymphadenectomy","volume":"183","author":"Marconnet","year":"2010","journal-title":"J Urol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2010.04.008","article-title":"Prognostic factors in penile cancer","volume":"76","author":"Ficarra","year":"2010","journal-title":"Urology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.7078","article-title":"The prognostic role of HPV or p16INK4a status in penile squamous cell carcinoma: A meta-analysis","volume":"23","author":"Mustasam","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30682-X","article-title":"Prevalence of human papillomavirus DNA and p16INK4a in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis","volume":"20","author":"Olesen","year":"2019","journal-title":"Lancet Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3880","article-title":"Immunotherapy: checkpoint parley","volume":"15","author":"Bordon","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1126\/SCIENCE.1056154","article-title":"Human DNA repair genes","volume":"291","author":"Wood","year":"2001","journal-title":"Sci (1979)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/NG0195-48","article-title":"Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability","volume":"9","author":"Liu","year":"1995","journal-title":"Nat Genet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100336","article-title":"Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers","volume":"7","author":"Palmeri","year":"2022","journal-title":"ESMO Open"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.874213","article-title":"Immunotherapy in penile squamous cell carcinoma: present or future? Multi-target analysis of programmed cell death ligand 1 expression and microsatellite instability","volume":"9","author":"Montella","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.48002","article-title":"Genomic profiles and clinical outcomes of penile squamous cell carcinoma with elevated tumor mutational burden","volume":"6","author":"Necchi","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/J.JBI.2008.08.010","article-title":"Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J BioMed Inform"},{"key":"B21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/J.EURURO.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs\u2014Part A: renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS14246024\/S1","article-title":"Prognostic significance of p16 and its relationship with human papillomavirus status in patients with penile squamous cell carcinoma: results of 5 years follow-up","volume":"14","author":"Chahoud","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-9-126","article-title":"Heterogenous mismatch-repair status in colorectal cancer","volume":"9","author":"Joost","year":"2014","journal-title":"Diagn Pathol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/EJHG.2013.256","article-title":"Optimization of a pentaplex panel for MSI analysis without control DNA in a Brazilian population: correlation with ancestry markers","volume":"22","author":"Campanella","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25611","article-title":"Advantage of HSP110 (T17) marker inclusion for microsatellite instability (MSI) detection in colorectal cancer patients","volume":"9","author":"Berardinelli","year":"2018","journal-title":"Oncotarget"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1590\/0100-6991e-20233586-en","article-title":"Epidemiological study of penile cancer in a northeastern state - Brazil","volume":"50","author":"Silva","year":"2023","journal-title":"Rev Col Bras Cir"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/S00345-022-04184-Z","article-title":"Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penis","volume":"41","author":"Tappero","year":"2023","journal-title":"World J Urol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1590\/S1677-5538.IBJU.2021.0613.1","article-title":"Risk factors for inguinal lymph node metastasis in patients with penile cancer","volume":"48","author":"Koifman","year":"2022","journal-title":"Int Braz J Urol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1590\/S1677-5538.IBJU.2018.0756","article-title":"External validation of nomogram to predict inguinal lymph node metastasis in patients with penile cancer and clinically negative lymph nodes","volume":"45","author":"Maciel","year":"2019","journal-title":"Int Braz J Urol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1038\/s41598-020-59831-5","article-title":"Profile of patients with penile cancer in the region with the highest worldwide incidence","volume":"10","author":"Vieira","year":"2020","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-18-0322","article-title":"Prognostic significance of HPV and p16 status in men diagnosed with penile cancer: A systematic review and meta-analysis","volume":"27","author":"Sand","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.02894\/ASSET\/952C46E9-A10D-4602-B6A1-46D451CFDB12\/ASSETS\/IMAGES\/LARGE\/JCO.22.02894APP3.JPG","article-title":"Atezolizumab with or without radiotherapy for advanced squamous cell carcinoma of the penis (The PERICLES study): A phase II trial","volume":"41","author":"De Vries","year":"2023","journal-title":"J Clin Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2009.07.007","article-title":"Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma","volume":"141","author":"Zuo","year":"2009","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22137069","article-title":"Molecular landscape of vulvar squamous cell carcinoma","volume":"22","author":"Carreras-Dieguez","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-015-9856-2","article-title":"Mismatch repair deficiency concordance between primary colorectal cancer and corresponding metastasis","volume":"15","author":"Haraldsdottir","year":"2016","journal-title":"Fam Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.7308","article-title":"Comparison of mismatch repair status between primary and matched metastatic sites in patients with colorectal cancer","volume":"17","author":"He","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103137","article-title":"Discordance of immunotherapy response predictive biomarkers between primary lesions and paired metastases in tumours: A systematic review and meta-analysis","volume":"63","author":"Zou","year":"2021","journal-title":"EBioMedicine"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2025.3266","article-title":"Pembrolizumab plus platinum-based chemotherapy for patients with advanced penile cancer: the nonrandomized HERCULES (LACOG 0218) clinical trial","volume":"11","author":"Cotait Maluf","year":"2025","journal-title":"JAMA Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.e15169","article-title":"Correlation between TMB and MSI in patients with solid tumors","volume":"38","author":"Zhao","year":"2020","journal-title":"J Clin Oncol"}],"container-title":["Frontiers in Urology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fruro.2026.1908537\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T04:44:11Z","timestamp":1787719451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fruro.2026.1908537\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":39,"alternative-id":["10.3389\/fruro.2026.1908537"],"URL":"https:\/\/doi.org\/10.3389\/fruro.2026.1908537","relation":{},"ISSN":["2673-9828"],"issn-type":[{"value":"2673-9828","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"article-number":"1908537"}}